NAMP
GSK icon

NorthStar Asset Management (Pennsylvania)’s GSK GSK Stock Holding History

NorthStar Asset Management (Pennsylvania)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,005
Closed -$231K – 144
2024
Q2 		$231K Buy
6,005
+728
+14% +$30.6K 0.06% 137
2024
Q1 		$226K Buy
+5,277
New +$218K 0.06% 140
2013
Q3 		– Sell
-5,914
Closed -$369K – 99
2013
Q2 		$369K Buy
+5,914
New +$375K 0.16% 77

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NorthStar Asset Management (Pennsylvania)'s GSK Position: Q3 2024 in Review

NorthStar Asset Management (Pennsylvania) sold out of GSK (GSK) in Q3 2024, closing a stake of 6,005 shares — an estimated $231K sold.

NorthStar Asset Management (Pennsylvania) first reported a position in GSK in Q2 2013 and held it in 3 quarters. The position peaked at $369K in Q2 2013. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

  • NorthStar Asset Management (Pennsylvania) reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
  • NorthStar Asset Management (Pennsylvania) sold 6,005 GSK shares in Q3 2024, an estimated $231K.
  • NorthStar Asset Management (Pennsylvania) first reported a position in GSK in Q2 2013 and held it in 3 quarters.
  • NorthStar Asset Management (Pennsylvania)'s GSK position peaked at $369K in Q2 2013.
  • 899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q3 2024, filed 30 Oct 2024.